Rethinking Innovation: Why Biotech is Thriving in LA
Hybrid event: in-person at MannKind Corporation (Westlake Village) or virtual on Zoom
Thursday, December 01, 2022
5:00 PM - 7:30 PM
Add to Calendar
Pacific Standard Time
Innovation and resilience are key to successful growth for LA biotechnology companies. Two years of pandemic uncertainty and geopolitical unrest have changed dynamics across all industries. LA Biotechnology companies are successfully navigating these uncharted waters, and rapid innovation is cause for enthusiasm. More than 6,000 drugs are currently in active development, including 800 next-gen biotherapeutics, with emerging biotechs leading the charge. Trends in innovation extend beyond novel mechanisms and platforms; companies are prioritizing ESG and the industry is rethinking clinical trial design to ensure diverse, representative recruitment and to get drugs to market faster. Investors are optimistic that biotech will outperform the broader market, and LA’s thriving biotech scene is well-positioned to spearhead this continued progress. Join the HBA LA and leaders from small biotechs in the area to reflect on 2022 and share their outlooks and optimism for the future of the industry in our region.